CN1253136A - 噻唑烷类衍生物及其医药用途 - Google Patents
噻唑烷类衍生物及其医药用途 Download PDFInfo
- Publication number
- CN1253136A CN1253136A CN 99120250 CN99120250A CN1253136A CN 1253136 A CN1253136 A CN 1253136A CN 99120250 CN99120250 CN 99120250 CN 99120250 A CN99120250 A CN 99120250A CN 1253136 A CN1253136 A CN 1253136A
- Authority
- CN
- China
- Prior art keywords
- compound
- formula
- thiazolidine
- hydrate
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB991202503A CN1183130C (zh) | 1999-09-24 | 1999-09-24 | 噻唑烷类衍生物及其医药用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB991202503A CN1183130C (zh) | 1999-09-24 | 1999-09-24 | 噻唑烷类衍生物及其医药用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1253136A true CN1253136A (zh) | 2000-05-17 |
CN1183130C CN1183130C (zh) | 2005-01-05 |
Family
ID=5281443
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB991202503A Expired - Lifetime CN1183130C (zh) | 1999-09-24 | 1999-09-24 | 噻唑烷类衍生物及其医药用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN1183130C (zh) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001044240A1 (en) * | 1999-12-18 | 2001-06-21 | Richter Gedeon Vegyészeti Gyár Rt. | Antidiabetic thiazolidinediones and their preparation |
WO2002026736A1 (en) * | 2000-09-29 | 2002-04-04 | Smithkline Beecham P.L.C. | A thiazolidinedione derivative and its use as antidiabetic |
WO2002060899A1 (en) * | 2001-01-31 | 2002-08-08 | Laboratorios Vita, S.A. | New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
JP2004508369A (ja) * | 2000-09-06 | 2004-03-18 | スミスクライン ビーチャム パブリック リミテッド カンパニー | 5−[4−[2−(n−メチル−n−(2−ピリジル)アミノ)エトキシ]ベンジル]チアゾリジン−2,4−ジオンの塩酸塩 |
JP2004509959A (ja) * | 2000-09-29 | 2004-04-02 | スミスクライン ビーチャム パブリック リミテッド カンパニー | 5−’4−’2−(n−メチル−n−(2−ピリジル)アミノ)エトキシ]ベンジル]チアゾリジン−2,4−ジオンのナトリウム塩 |
-
1999
- 1999-09-24 CN CNB991202503A patent/CN1183130C/zh not_active Expired - Lifetime
Cited By (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001044240A1 (en) * | 1999-12-18 | 2001-06-21 | Richter Gedeon Vegyészeti Gyár Rt. | Antidiabetic thiazolidinediones and their preparation |
EP1475378A1 (en) * | 1999-12-18 | 2004-11-10 | Richter Gedeon Vegyeszeti Gyar R.T. | Antidiabetic thiazolidinedione potassium salt |
JP2004508369A (ja) * | 2000-09-06 | 2004-03-18 | スミスクライン ビーチャム パブリック リミテッド カンパニー | 5−[4−[2−(n−メチル−n−(2−ピリジル)アミノ)エトキシ]ベンジル]チアゾリジン−2,4−ジオンの塩酸塩 |
WO2002026736A1 (en) * | 2000-09-29 | 2002-04-04 | Smithkline Beecham P.L.C. | A thiazolidinedione derivative and its use as antidiabetic |
JP2004509960A (ja) * | 2000-09-29 | 2004-04-02 | スミスクライン ビーチャム パブリック リミテッド カンパニー | チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用 |
JP2004509959A (ja) * | 2000-09-29 | 2004-04-02 | スミスクライン ビーチャム パブリック リミテッド カンパニー | 5−’4−’2−(n−メチル−n−(2−ピリジル)アミノ)エトキシ]ベンジル]チアゾリジン−2,4−ジオンのナトリウム塩 |
AU2001292034B2 (en) * | 2000-09-29 | 2005-04-21 | Smithkline Beecham P.L.C. | A thiazolidinedione derivative and its use as antidiabetic |
EP1795531A1 (en) * | 2000-09-29 | 2007-06-13 | Smithkline Beecham Plc | A thiazolidinedione derivative and its use as antidiabetic |
CN100345846C (zh) * | 2000-09-29 | 2007-10-31 | 史密斯克莱·比奇曼公司 | 5-[4-[2-(n-甲基-n-(2-吡啶基)氨基)乙氧基]苄基]噻唑烷-2,4-二酮的钠盐 |
CN1915992B (zh) * | 2000-09-29 | 2010-05-12 | 史密斯克莱.比奇曼公司 | 5-[4-[2-(n-甲基-n-(2-吡啶基)氨基)乙氧基]苄基]噻唑烷-2,4-二酮的钠盐 |
CN1620453B (zh) * | 2000-09-29 | 2010-12-08 | 史密斯克莱·比奇曼公司 | 噻唑烷二酮衍生物及其作为抗糖尿病药的用途 |
WO2002060899A1 (en) * | 2001-01-31 | 2002-08-08 | Laboratorios Vita, S.A. | New salt of thiazolidinedione and its polymorphs as antidiabetic agents and method for obtaining them |
Also Published As
Publication number | Publication date |
---|---|
CN1183130C (zh) | 2005-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2405972B1 (en) | Use of rosuvastatin lactols as medicaments | |
CN103068384B (zh) | 表现出抗癌和抗增生活性的环丙基二甲酰胺以及类似物 | |
SA99200059A (ar) | مركبات إميدازول جديدة مستبدلة | |
CZ120398A3 (cs) | Použití 2-alkylpyrrolidinových derivátů pro přípravu léčiva pro léčbu diabetu, 2-alkylpyrrolidiné deriváty | |
US11267806B2 (en) | Indazole compound for use in inhibiting kinase activity, composition and application thereof | |
US5350582A (en) | Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof | |
CN103298805A (zh) | 喹唑啉化合物及其使用方法 | |
JP2013532121A (ja) | チアゾリジンジオン化合物のための新規な合成 | |
US9006282B2 (en) | Rosuvastatin and atorvastatin derivatives | |
CN108349965A (zh) | 1,3,4-噻二唑化合物及其在治疗癌症中的用途 | |
CN1183130C (zh) | 噻唑烷类衍生物及其医药用途 | |
EP2550966B1 (de) | Dabigatran-Amidoximsäureesters als Prodrugs und ihre Verwendung als Arzneimittel | |
EP3805203A1 (en) | Azetidine derivative, and prodrug thereof | |
CN111479808A (zh) | 嘧啶磺酰胺类衍生物、其制备方法及其在医药上的应用 | |
EP4155304A1 (en) | Compound used as ret kinase inhibitor and application thereof | |
EP2405911B1 (en) | Use of atorvastatin lactols as medicaments | |
CN107235960A (zh) | 酰胺类衍生物、其制备方法及其在医药上的用途 | |
EP2636671B1 (en) | Organic amine salts of aminobenzoic acid derivatives, and method for producing same | |
WO2005023803A1 (en) | Phosphoric acid salt of 5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl] methyl]- 2,4-thiazolidinedione | |
CN117586232A (zh) | 一种依达拉奉前药衍生物及其应用 | |
JPS631938B2 (zh) | ||
CN107304180A (zh) | 苯甲酰胺类衍生物、其制备方法及其在医药上的用途 | |
WO2005023790A1 (en) | (s)-(+)-2-ethoxy-4-{[3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid sodium salt | |
CA2360066A1 (en) | A pharmaceutical composition containing a compound having a phenolic hydroxyl group with coloring change being controlled | |
WO2005021543A1 (en) | Phosphoric acid salt of 5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2, 4-thiazolidinedione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: TAIJI GROUP CO., LTD. Free format text: FORMER OWNER: INST OF TOXIC MEDICINAL MATERIALS, P.L.A. ACADEMY OF MILITARY MEDICAL SCIENCES Effective date: 20070202 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20070202 Address after: 401147 No. 38 Huanglong Road, Chongqing, Yubei District Patentee after: Taiji Group Co., Ltd. Address before: 100850 No. 27 Taiping Road, Beijing Patentee before: Institute of Poisonous Substance and Medicine of Military of Military academy of medical sciences of |
|
C17 | Cessation of patent right | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20050105 Termination date: 20130924 |
|
C49 | Reinstatement of patent right or utility model | ||
RR01 | Reinstatement of patent right |
Former decision: cessation of patent right due to non-payment of the annual fee Former decision publication date: 20141126 |
|
CX01 | Expiry of patent term | ||
CX01 | Expiry of patent term |
Granted publication date: 20050105 |